FUSO PHARMACEUTICAL INDUSTRIES chart

Last update: 2021-02-19
Key statistics and financials
Revenue per share 5,369.30
Dividend & Yield60.00¥ (2.82%)
Beta 0.38
Market capitalization 18.62B
Operating cash flow 3.26B
ESG Scores unknown

Company description

Fuso Pharmaceutical Industries,Ltd. manufactures and sells pharmaceutical products in Japan. The company offers ethical drugs, such as injectables and artificial kidney dialysates; and medical machinery and equipment. It also rents real estate properties. The company was founded in 1937 and is headquartered in Osaka, Japan.

Sector: Healthcare - Industry: Drug Manufacturers—Specialty & Generic

Financial Ratios
Quick Ratio1.19
Working Capital0.36
Return On Equity0.15
Debt To Equity0.19
Fixed Asset Ratio0.01
Fixed Interest Cover14.51

Financial data

Financial Statements

Cashflow Statement 2010-03-31 2011-03-31 2012-03-31 2013-03-31
Change To Liabilities 367M -688M 97M 831M
Total Cashflows From Investing Activities -1.43B -1.34B -1.38B 2.42B
Net Borrowings -329M -4.24B 1.49B -282M
Total Cash From Financing Activities -878M -4.79B 943M -832M
Change To Operating Activities 49M 1.5B 179M 976M
Issuance Of Stock
Net Income 518M 1.14B 372M 4.87B
Change In Cash -125M 795M 445M 4.84B
Effect Of Exchange Rate -6M -13M -1M
Total Cash From Operating Activities 2.19B 6.94B 884M 3.26B
Depreciation 2.21B 2.09B 1.89B 1.75B
Change To Account Receivables 152M 2.02B -401M -3.17B
Other Cashflows From Financing Activities -1M -2M -3M -3M
Change To Netincome 97M 60M -4M -2.46B
Capital Expenditures -1.17B -1.01B -1.21B -1.93B

Income Statement 2010-03-31 2011-03-31 2012-03-31 2013-03-31
Research Development 3.66B 1.91B 1.74B 1.67B
Income Before Tax 572M 984M 7M 6.24B
Net Income 518M 1.14B 372M 4.87B
Selling General Administrative 9.53B 9.49B 9.73B 9.61B
Gross Profit 13.9B 13.81B 12.19B 15.32B
Ebit 464M 2.17B 481M 3.82B
Operating Income 464M 2.17B 481M 3.82B
Interest Expense -314M -306M -262M -263M
Income Tax Expense 54M -160M -365M 1.36B
Total Revenue 46.56B 47.47B 44.36B 48.61B
Cost Of Revenue 32.66B 33.66B 32.16B 33.3B
Total Other Income ExpenseNet 108M -1.19B -474M 2.42B
Net Income From Continuing Ops 518M 1.14B 372M 4.87B
Net Income Applicable To Common Shares 518M 1.14B 372M 4.87B

Balance Sheet Statement 2010-03-31 2011-03-31 2012-03-31 2013-03-31
Total Liabilities 37.74B 33.19B 34.93B 38.75B
Total Stockholder Equity 25.89B 26.26B 26.6B 33.1B
Other Current Liabilities 3.28B 4.95B 5.3B 7.34B
Total Assets 63.63B 59.45B 61.53B 71.85B
Common Stock 10.76B 10.76B 10.76B 10.76B
Other Current Assets 1.47B 767M 1.05B 913M
Retained Earnings 5.77B 6.37B 6.2B 10.84B
Treasury Stock -5.65B -5.88B -5.37B -3.51B
Cash 3.04B 3.83B 4.28B 9.12B
Total Current Liabilities 27.35B 23.29B 24.27B 27.54B
Other Stockholder Equity -4.25B -4.47B -3.96B -2.1B
Property, Plant, and Equipment 25.03B 24.07B 23.72B 22.49B
Total Current Assets 33.11B 30.1B 32.11B 40.89B
Net Tangible Assets 25.69B 26.06B 26.43B 32.72B
Net Receivables 21.06B 19.04B 19.44B 22.61B
Accounts Payable 13.48B 11.25B 11.35B 12.18B


Insider Transactions

Here are the insider transactions of stock shares related to FUSO PHARMACEUTICAL INDUSTRIES:

Filer Name Transaction Text Ownership Date Filer Relation Shares
NO DATA

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to FUSO PHARMACEUTICAL INDUSTRIES. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on FUSO PHARMACEUTICAL INDUSTRIES

Here is the result of two systematic investment strategies applied to FUSO PHARMACEUTICAL INDUSTRIES. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on FUSO PHARMACEUTICAL INDUSTRIES

The following chart shows the equity curve of the two systematic investment strategies applied to FUSO PHARMACEUTICAL INDUSTRIES:

FUSO PHARMACEUTICAL INDUSTRIES automated entries

The systematic investment strategy that buys the first day of the month would give a performance of -5.95% on the backtest period.

Performance at glance

Performance

-5.95 %

Latent gain

-681.0 ¥

Invested capital

11453.0 ¥

Annualized return

-1.42 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on FUSO PHARMACEUTICAL INDUSTRIES

This is the result of two momentum investment strategies applied to FUSO PHARMACEUTICAL INDUSTRIES. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on FUSO PHARMACEUTICAL INDUSTRIES

The following chart shows all the entries opened by the momentum investment system on FUSO PHARMACEUTICAL INDUSTRIES:

FUSO PHARMACEUTICAL INDUSTRIES momentum entries
  • The first momentum investment strategy would give -3.8% of return on FUSO PHARMACEUTICAL INDUSTRIES. That represents -319.0¥ of latent gain with 8398.0¥ of employed capital.
  • The second momentum investment strategy would give -3.27% of return on FUSO PHARMACEUTICAL INDUSTRIES. That represents -273.0¥ of latent gain with 8352.0¥ of employed capital.
Performance at glance (1Q Momentum)

Performance

-3.8 %

Latent gain

-319.0 ¥

Invested capital

8398.0 ¥

Annualized return

7.1 %
Performance at glance (2Q Momentum)

Performance

-3.27 %

Latent gain

-273.0 ¥

Invested capital

8352.0 ¥

Annualized return

-0.88 %

Momentum equity curve on FUSO PHARMACEUTICAL INDUSTRIES

The following chart shows the equity curve of the two momentum strategies applied to FUSO PHARMACEUTICAL INDUSTRIES:

FUSO PHARMACEUTICAL INDUSTRIES momentum equity

Note: the dividends potentially given by FUSO PHARMACEUTICAL INDUSTRIES are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on FUSO PHARMACEUTICAL INDUSTRIES

The following chart shows the employed capital evolution of the two momentum strategies on FUSO PHARMACEUTICAL INDUSTRIES since the beginning:

FUSO PHARMACEUTICAL INDUSTRIES

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250¥, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000¥.


Buy the dip strategy result on FUSO PHARMACEUTICAL INDUSTRIES

Buy the dip entry openings on FUSO PHARMACEUTICAL INDUSTRIES

FUSO PHARMACEUTICAL INDUSTRIES

The performance achieved by the robo-advisor on FUSO PHARMACEUTICAL INDUSTRIES is 15.63%. That represents 1456.0$ of latent gain with 9316.0¥ of employed capital. The following chart shows FUSO PHARMACEUTICAL INDUSTRIES stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of FUSO PHARMACEUTICAL INDUSTRIES, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

15.63 %

Latent gain

1456.0 ¥

Invested capital

9316.0 ¥

Annualized return

7.1 %

Equity curve of the strategy applied to FUSO PHARMACEUTICAL INDUSTRIES

The following chart shows the result of the investment strategy applied to FUSO PHARMACEUTICAL INDUSTRIES:

FUSO PHARMACEUTICAL INDUSTRIES

Note: the dividends potentially given by FUSO PHARMACEUTICAL INDUSTRIES are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on FUSO PHARMACEUTICAL INDUSTRIES

The following chart shows the employed capital evolution since the beginning of the investment strategy on FUSO PHARMACEUTICAL INDUSTRIES:

FUSO PHARMACEUTICAL INDUSTRIES

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on FUSO PHARMACEUTICAL INDUSTRIES

In this section, I will compare the three previous investment strategies applied to FUSO PHARMACEUTICAL INDUSTRIES.

Equity curve comparison on FUSO PHARMACEUTICAL INDUSTRIES

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

FUSO PHARMACEUTICAL INDUSTRIES investment strategy comparison

Employed capital comparison on FUSO PHARMACEUTICAL INDUSTRIES

FUSO PHARMACEUTICAL INDUSTRIES investment comparison

Performance comparison on FUSO PHARMACEUTICAL INDUSTRIES

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment -5.95% -681.0¥ 11453.0¥ -1.42%
Momentum 1 quarter -3.8% -319.0¥ 8398.0¥ -0.96%
Momentum 2 quarters -3.27% -273.0¥ 8352.0¥ -0.88%
Non-directional 15.63% 1456.0¥ 9316.0¥ 7.1%
Annualized return comparison

Automatic investment

-1.42 %

Momentum 1Q

-0.88 %

Momentum 2Q

-0.88 %

Non-directional

7.1 %

Correlated stocks

Here are the most positively and negatively correlated stocks with FUSO PHARMACEUTICAL INDUSTRIES:

Positive correlations

Most correlated stocks this year


Most correlated stocks last 3 months

Negative correlation

Most negatively correlated stocks this year


Most negatively correlated stocks last 3 months

Note: The algorithm computes the probability of correlation between FUSO PHARMACEUTICAL INDUSTRIES and the other stocks. There may be false positives or some missing correlated stocks. If the price of FUSO PHARMACEUTICAL INDUSTRIES does not vary for 36 weeks, the correlation calculation result will be wrong.


Company information

Company name FUSO PHARMACEUTICAL INDUSTRIES
Country Japan
City Osaka
Address 1-7-10, Doshomachi
Phone
Website www.fuso-pharm.co.jp
FullTime employees 1370
Industry Drug Manufacturers—Specialty & Generic
Sector Healthcare
Exchange XTKS
Ticker 4538.XTKS
Market www.jpx.co.jp

FUSO PHARMACEUTICAL INDUSTRIES ESG Scores

Environment scores

Environment ESG Factors Scores
Environment Score 0
Peer Environment Performance unknown
Environment Percentile unknown
Palm Oil unknown
Nuclear unknown
Fur Leather unknown
GMO unknown
Coal unknown
Pesticides unknown
Animal Testing unknown

Social scores

Social ESG Factors Scores
Social Score 0
Peer Social Performance unknown
Social Percentile unknown
Highest Controversy unknown
Peer Highest Controversy Performance unknown
Adult unknown
Gambling unknown
Alcoholic unknown
Tobacco unknown
Catholic unknown
Controversial Weapons unknown
Small Arms unknown
Military Contract unknown
Peer Count unknown

Related Controversy:


Governance scores

Governance ESG Factors Scores
Governance Score 0
Peer Governance Performance unknown
Governance Percentile unknown

ESG at glance
Total ESG Scores: unknown
Environment Score: 0
Social Score: 0
Governance Score: 0

ESG Performance: unknown

Peer Group: unknown

Peer Esg Score Performance: unknown

Rating Year: unknown

Rating Month: unknown

Max Age: unknown

Percentile: unknown